Glutathione

Glutathione is a tripeptide of glutamate, cysteine, and glycine (gamma-L-glutamyl-L-cysteinylglycine) and the principal intracellular antioxidant in human cells. It cycles between a reduced (GSH) and oxidized (GSSG) form, and that redox couple is fundamental to cellular protection, detoxification, and signaling ^[3].

Because orally ingested glutathione is largely broken down during digestion, its bioavailability is a long-standing question, and it is delivered in oral, topical, liposomal, and injectable forms with differing absorption ^[3][2]. It is used both as a systemic antioxidant and, especially across parts of Asia, as a cosmetic skin-lightening agent ^[4].

Its research applications concentrate on skin pigmentation and antioxidant status. A randomized, double-blind, placebo-controlled trial found that oral glutathione lowered the skin melanin index at sun-exposed sites over four weeks, with reductions reaching significance at the face and forearm and parallel decreases in ultraviolet spots ^[1]. A double-blind randomized trial reported that combining topical and oral glutathione lowered the melanin index more than either alone ^[2], while systematic reviews conclude the skin-whitening evidence is promising but still inconsistent and limited by absorption and study quality, with oral forms generally well tolerated and parenteral forms less so ^[4][3]. Reviews also note associated cosmetic effects such as improved skin elasticity and reduced wrinkles ^[4].

Glutathione is regulated as a dietary supplement in oral form in the United States; intravenous skin-lightening use is not an approved indication and has drawn safety warnings in some countries. It is sold as capsules, topical preparations, and injectable solutions.

Oral glutathione has been well tolerated in the controlled trials that measured it, at 250 to 1,000 mg a day for as long as six months ^[7][20][22]. The problems belong to the other routes.

Intravenous glutathione sold for skin lightening is the serious one. Adverse effects reported with it led the Food and Drug Administration of the Philippines to issue a public warning against off-label cosmetic use, and the reported harms include severe skin eruptions such as Stevens-Johnson syndrome, kidney and thyroid dysfunction, and infection from unregulated preparations ^[30][31]. Parenteral glutathione does have legitimate approved uses, for severe liver disorders and for preventing chemotherapy neurotoxicity, and the harm reports come from the cosmetic market rather than from those ^[31]. A 2016 review of the whole literature found no study at all of intravenous glutathione for skin lightening, and none of its safety in long-term use for any indication ^[32]. A 2025 systematic review states plainly that the intravenous route is contraindicated for pigmentation, for want of efficacy and because of the side effects ^[11]. One consequence rarely appears in marketing: the shift from eumelanin toward lighter pheomelanin that produces the lightening also removes pigment that was protecting the skin, which may raise the risk of sun-induced skin cancer in people who were previously protected; that is reasoning from mechanism rather than a measured outcome, and no study has tested it ^[32].

Nebulized glutathione should be avoided in asthma. In a randomized crossover challenge, 600 mg by nebulizer cut FEV1 by 19 percent and caused cough or breathlessness in most of the eight patients tested, an effect blocked by salbutamol and attributed to sulfite formation ^[23]. Intranasal glutathione is better behaved and was tolerable across three months at 300 to 600 mg a day in Parkinson's disease, though one participant on the high dose in the phase IIb trial developed cardiomyopathy ^[15][17]. Nothing about the injectable route should be treated as risk-free.

Two case reports published in 2025 put names to what the reviews had only counted. A 33-year-old woman developed Stevens-Johnson syndrome overlapping toxic epidermal necrolysis after an intravenous infusion containing glutathione, vitamin C and vitamin D at a wellness clinic; the infusion was a mixture, so the tripeptide cannot be isolated as the cause, and the report's own point is that glutathione has been the named agent in earlier cases and that this is the association behind the Philippine warning ^[47]. A previously healthy woman collapsed within an hour of a high-dose unregulated glutathione drip sold for skin lightening, with a temperature above 41 degrees, a white cell count of 26, acute liver injury and a coagulopathy, and no infection found; she recovered with supportive care, and her authors attribute it either to endotoxin in the product or to a very large glutathione load in someone who had been eating very little ^[48]. Neither case is proof of causation on its own. Both describe the same setting, which is an unregulated infusion given outside a clinical service.

Regulators have taken the same view from both ends. The Philippine agency's warning is the one the dermatology literature keeps citing ^[30][31]. In the United States the Food and Drug Administration has approved no injectable drug for skin lightening at all, and its consumer guidance names glutathione among the ingredients in the products it warns about, alongside infection, clots and blood-borne infection from the injection itself rather than from the molecule. The case report of the collapse above notes that the product involved has no regulatory approval in the United Kingdom either ^[48]. Oral and topical glutathione sit in an entirely different regulatory place and carry none of this.

Glutathione has few documented drug interactions, and the ones worth knowing are about its chemistry rather than about metabolism. It is the substrate for the glutathione S-transferases of phase II conjugation, so in principle it sits in the clearance pathway for a very large number of drugs; no clinical interaction has actually been demonstrated from supplementing it, and the effect of an oral dose on hepatic conjugation has never been measured in a person. Nebulized glutathione is the clear one to avoid alongside anything that raises bronchial reactivity: in mild asthma 600 mg by nebulizer cut FEV1 by 19 percent, an effect attributed to sulfite formation and blocked by salbutamol ^[23].

Anyone with a known sulfite sensitivity should treat inhaled preparations the same way. With chemotherapy the picture is genuinely reassuring rather than alarming; intravenous glutathione given before oxaliplatin reduced grade 2 to 4 neurotoxicity without reducing the response rate to the chemotherapy itself ^[29], although the larger phase 3 trial in paclitaxel and carboplatin found no neuropathy benefit at all ^[28], so this belongs to the oncologist and not to a supplement shelf. Injectable glutathione sold for cosmetic use is commonly combined with high-dose intravenous vitamin C, and the regulator warnings apply to the whole practice ^[31][32]. This is research information, not medical advice.

Checking a whole stack? Run it through interactions + stacks.

Glutathione was first observed in 1888 by the French scientist J. de Rey-Pailhade, who named the sulfur-containing substance he found in yeast and animal tissues "philothion." Its identity as a tripeptide of glutamate, cysteine, and glycine was established in the 1920s, notably through the work of the British biochemist and Nobel laureate Frederick Gowland Hopkins, with later refinement by Edward Calvin Kendall and others. Recognized as the body's principal intracellular antioxidant, glutathione became a cornerstone of redox biology and detoxification research through the twentieth century. Its use as a skin-brightening agent is more recent, arising from the observation that it inhibits melanin synthesis, and this application has been tested in controlled studies such as a 2010 randomized trial of oral glutathione.

Glutathione is held in high regard across biochemistry and medicine as the cell's "master antioxidant," central to neutralizing free radicals, powering liver detoxification, and regenerating vitamins C and E. In dermatology and consumer wellness it has built a devoted following as a skin-brightening agent, supported by randomized trials showing measurable reductions in skin melanin, especially in sun-exposed areas. It is valued as a single, naturally occurring molecule that both defends cells and supports a clearer complexion, and oral use is generally very well tolerated. In the interest of honesty, oral bioavailability is limited and skin-lightening effects are modest and not always durable, which is part of why injectable and topical forms exist.